A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19.

Vyrologix (leronlimab) - CytoDyn, Vyera Pharma, amfAR

http://www.ncbi.nlm.nih.gov/pubmed/39353749

Ali Mansour; Arvin Cyrus Arman; Daniel Sammartino; Harish Seethamraju; Jacob P Lalezari; Jonah B Sacha; Onyema Ogbuagu; Otto O Yang; Richard Loftus; Scott G Hansen; Sohita Ojha

Oct 3, 2024